Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-20
2008-08-12
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S402000, C514S422000, C514S365000, C514S444000, C548S315400, C548S560000, C548S202000, C549S074000, C549S491000, C564S244000
Reexamination Certificate
active
07410999
ABSTRACT:
The present invention relates to novel compounds and methods that are useful in treating members of the Flaviviridae family of viruses. Compounds of the present invention will have a structure according to Formulas (I)-(VI) as recited throughout the application.
REFERENCES:
patent: 2641601 (1953-06-01), Goldberg et al.
patent: 4153703 (1979-05-01), Harrison et al.
patent: 5602172 (1997-02-01), Boykin et al.
patent: 5667975 (1997-09-01), Dykstra et al.
patent: 5668165 (1997-09-01), Wuonola et al.
patent: 5723288 (1998-03-01), Dykstra et al.
patent: 5843980 (1998-12-01), Hall et al.
patent: 5935776 (1999-08-01), Green et al.
patent: 6008247 (1999-12-01), Boykin et al.
patent: 6613787 (2003-09-01), Wilson et al.
patent: 6635668 (2003-10-01), Tidwell et al.
patent: 6774144 (2004-08-01), Dykstra et al.
patent: 6867227 (2005-03-01), Wilson et al.
patent: 2002/0156098 (2002-10-01), Werbovetz et al.
patent: 2003/0083362 (2003-05-01), Boykin et al.
patent: 2004/0053481 (2004-03-01), Wilson et al.
patent: 2005/0158785 (2005-07-01), Wilson et al.
patent: 641607 (1964-06-01), None
patent: 941991 (1999-09-01), None
patent: 1464999 (1965-12-01), None
patent: 1084175 (1967-09-01), None
patent: 54014970 (1979-02-01), None
patent: 179856 (1995-07-01), None
patent: WO 9615126 (1996-05-01), None
patent: WO 01/03685 (2001-01-01), None
patent: WO 0132159 (2001-05-01), None
patent: WO 01/46175 (2001-06-01), None
patent: 02/36588 (2002-05-01), None
Baginski et al. PNAS 2000, 97(14), 7981-7986.
Communication pursuant to Rule 44a EPC corresponding to European application No. 07110507.6-2117 dated Oct. 17, 2007.
European Office Action corresponding to EP application No. 02 705 743.9-2117 dated May 26, 2006.
Australian First Report corresponding to Australian Patent Application No. 2002239873 dated Oct. 21, 2005.
European Search Report for corresponding European app. No. 02705743.9 dated Jul. 15, 2005.
Givens et al.Anti Microbial Agents and Chemotherapy, 47(7): 2223-2230, 2003.
International Search Report for PCT/US02/00787 (Sep. 12, 2002).
Lansiaux et al.,Journal of Medicinal Chemistry, 45: 1994-2002, 2002.
Davis et al., CA 134:39002,2000.
Wang et al., “Evaluation of the Influence of Compound Structure on Stacked-Dimer Formation in the DNA Minor Groove”,Biochemistry, 40: 2511-2521, 2001.
Wang et al., “Specific Molecular Recognition of Mixed Nucleic Acid Sequences: An Aromatic Dication that Binds in the DNA minor Groove as a Dimer”,PNAS, 97(1): 12-16, Jan. 4, 2000.
Gelus et al., “Inhibition of HIV-1 Tat-TAR Interaction by Diphenylfuran Derivatives: Effects of the Terminal Basic Side Chains”,Bioorganic&Medicinal Chemistry, 7: 1089-1096, 1999.
Del Poeta et al. “In Vitro Antifungal Activities of a Series of Dictation-Substituted Carbazoles, Furans, and Benzimidazoles”,Antimicrobial Agents and Chemotherapy, 42(10): 2503-2510, Oct. 1998.
Blagburn et al., CA 129:297986, 1998.
Boykin et al., “2,5-Bis[4-(N-alkylamidino)phenyl]furans as Anti-Pneumocystis carinii Agents,” Journal of Medicinal Chemistry (1998), 41 (1), pp. 124-129.
Zapp et al., “Modulation of the Rev-RRE Interaction by Aromatic Heterocyclic Compounds”,Bioorganic&Medicinal Chemistry, 5 (6): 1149-1155, 1997.
Neidle et al., CA 127:103988, 1997.
Boykin et al., “Anti-Pneumocystis Activity of Bis-Amidoximes and Bis-O-Alkylamidoximes Prodrugs”,Bioorganic&Medicinal Chemistry Letters, 6 (24): 3017-3020, 1996.
Ratmeyer et al., “Inhibition of HIV-1 Rev-RRE Interaction by Diphenylfuran Derivatives”,Biochemistry, 35: 13689-13696, 1996.
Boykin et al., “Dicationic Diarylfurans as Anti-Pneumocystis carinii Agents,” CA 122:230122, 1995.
Tralic-Kulenovic et al., “Synthesis and Absorption Spectral Properties of Substituted Phenylfurylbenzothiazoles and their Vinylogues”,Monatshefte fur Chemie, 125: 209-215, 1994.
Steck et al., “Leishmania donovani, Plasmodium berghei, Trypanosoma rhodesiense: antiprotozoal effects of some admidine types,” CA 96:135352, 1982.
De Clereq et al., “Diaryl Amidine Derivatives as Oncornaviral DNA Polymerase Inhibitors”,J. Med. Chem., 23: 787-795, 1980.
Das et al., “Synthesis and Antiprotozoal Activity of 2,5-Bis(4-guanylphenyl)furans,” Journal of Medicinal Chemistry (1977), 20(4), pp. 531-536.
Official Action corresponding to an Japanese Patent Application No. 2002555762 dated Jan. 22, 2008.
Boykin David
Brock Kenny
Dykstra Christine C.
Givens Maurice Daniel
Kumar Arvid
Anderson Rebecca L
Auburn University
Georgia State University Research Foundation, Inc.
Jenkins Wilson Taylor & Hunt, P.A.
Nolan Jason M
LandOfFree
Compounds, methods and compositions useful for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, methods and compositions useful for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds, methods and compositions useful for the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012082